Objectives: Uric acid has an important role in the production of various inflammatory
cytokines such as tumor necrosis factor-α (TNF-α). Although serum uric acid
levels in various rheumatic diseases have been performed the relationships
between serum uric acid levels with inflammatory markers and Bath Ankylosing
Spondylitis Disease Activity Index (BASDAI) scores in ankylosing spondylitis
patients treated with anti-TNF-α and nonsteroid anti-inflammatory drugs
(NSAIDs) have not been described yet. The aim of this study was to compare the
relationships between serum uric acid levels, inflammatory markers and BASDAI
scores in ankylosing spondylitis patients treated anti-TNF-α and NSAIDs.
Methods: A total of 132 ankylosing spondylitis patients fulfilling the 1984 Modified New
York Criteria who had serum uric acid, erythrocyte sedimentation rate and
C-reactive protein levels in medical records were included in this retrospective
cross-sectional study. Patients were divided in two groups (anti-TNF-α and
NSAIDs). Their files were examined in detail. Later demographic and laboratory
features were recorded to the research form.
Results: Serum uric acid
levels were significantly lower in the anti-TNF-α group (mean: 4.9 mg/dL,
range: 4.10-5.45 mg/dL) than in the NSAIDs group (mean: 5.20 mg/dL, range
4.70-5.90 mg/dL) (p = 0.021). Also,
positive correlations were found between C-reactive protein (p = 0.003) and BASDAI (p = 0.009) with serum uric acid.
Conclusions: According to this study, we can consider
that serum uric acid level could be used as an inflammatory laboratory marker,
such as C-reactive protein in ankylosing spondylitis patients. However, we
believe that more studies are needed about this research.
Birincil Dil | İngilizce |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | Original Article |
Yazarlar | |
Yayımlanma Tarihi | 4 Ocak 2019 |
Gönderilme Tarihi | 29 Kasım 2017 |
Kabul Tarihi | 21 Ocak 2018 |
Yayımlandığı Sayı | Yıl 2019 Cilt: 5 Sayı: 1 |